7643.T
The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.
Business. The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.
The company maintains a strong liquidity position, with a current ratio of 1.75, indicating that it has sufficient current assets to cover its current liabilities. Its liquidity_fpt score further supports this, showing a low liquidity risk. The company's capital structure is also robust, with a debt-to-equity ratio of 0.07, suggesting that it is not heavily leveraged and has a strong equity base.
In terms of profitability, the company's return on equity (ROE) is 5.69%, and its return on assets (ROA) is 3.58%. These figures are in line with the industry's preferred metrics, indicating that the company is generating returns that are consistent with its peers. The company's operating income of 1,355,149,000 JPY and net income of 979,425,000 JPY further support its profitability.
The company's revenue is primarily concentrated in its core retail operations, with no significant geographic diversification reported. This concentration may pose a risk if the company's primary market experiences economic downturns or regulatory changes.
The company's growth trajectory is positive, with a strong operating cash flow of 1,703,100,000 JPY and a free cash flow of 659,078,000 JPY. These figures suggest that the company has the financial flexibility to invest in growth opportunities or return value to shareholders. The outlook for the current fiscal year indicates continued growth, with revenue expected to increase in the next fiscal year.
The company's risk assessment indicates a low risk of dilution and no immediate filing-based liquidity or dilution flags. This suggests that the company is not expected to issue additional shares in the near term, which could potentially dilute existing shareholders' equity. The company's capital structure and financial flexibility further support this low risk profile.
Recent events, including filings and transcripts, have not indicated any significant changes in the company's operations or financial strategy. The company continues to focus on its core retail operations and has not announced any major new initiatives or strategic shifts.
- The company has a strong liquidity position with a current ratio of 1.75.
- The company's profitability metrics, including ROE and ROA, are in line with industry standards.
- The company's revenue is primarily concentrated in its core retail operations.
- The company has a positive growth trajectory with strong operating and free cash flows.
- The company has a low risk of dilution and no immediate liquidity concerns.
- "margin_outlook_rationale": "The company's gross profit margin is stable, supported by consistent revenue and cost management.",
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 7643.T Market data — financials · 2026-05-27